SCHEMBL13019690

SCHEMBL13019690

CC(C)(C)c1nc(C(F)(F)F)c(C#N)s1

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13306829 0.86
SCHEMBL17481226 0.77 COMT (0.40) P2RY1
SCHEMBL20782577 0.75 P2RY1 (0.33) P2RY1
SCHEMBL20909349 0.74 SMN1; SMN2 (0.34) P2RY1
SCHEMBL8555203 0.73 P2RY1 (0.43) P2RY1
SCHEMBL20711405 0.72 P2RY1 (0.34) P2RY1
SCHEMBL14329572 0.70 MEN1 (0.30)
SCHEMBL9224524 0.69 P2RY1 (0.43) P2RY1
SCHEMBL13306871 0.68
SCHEMBL10242313 0.67 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES DDT, ACHE, TPM3 P2RY1 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.